🔗 Visit the ClinicalTrials.gov page for NCT01794182
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Glibenclamide for the treatment of acute CNS injury. | Pharmaceuticals (Basel) | 2013 | 0.96 |
| 2 | The Sur1-Trpm4 Channel in Spinal Cord Injury. | J Spine | 2013 | 0.84 |
| 3 | Effect of glibenclamide on the prevention of secondary brain injury following ischemic stroke in humans. | Neurosurg Focus | 2014 | 0.83 |
| 4 | MRI evidence that glibenclamide reduces acute lesion expansion in a rat model of spinal cord injury. | Spinal Cord | 2013 | 0.81 |
| 5 | Glibenclamide Is Comparable to Target Temperature Management in Improving Survival and Neurological Outcome After Asphyxial Cardiac Arrest in Rats. | J Am Heart Assoc | 2016 | 0.76 |
| 6 | Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial. | Lancet Neurol | 2016 | 0.76 |
| 7 | Advances in brain barriers and brain fluid research and news from Fluids and Barriers of the CNS. | Fluids Barriers CNS | 2016 | 0.75 |